Cardiovascular Management of Patients Undergoing Hematopoietic Stem Cell Transplantation
You are currently not logged in to PHD
To view this content, please login to your account, or within the login, click 'Create an Account' for guest access. To access AHA's full array of membership benefits, join or renew today!
Salim Hayek, MD, a cardiovascular specialist in cardio-oncology from the UTMB Health is joined by Amelia Langston, MD, a hematology and medical oncology specialist from Emory University to discuss their new AHA scientific statement on the cardiovascular management of patients undergoing hematopoietic stem cell transplantation (HSCT). They review the phases of HCST, the incidence of cardiovascular complications, long-term management, and the significance of survivorship post-transplant.
Recommended Videos
Cardiac Cath Lab Assessment of Comatose Patient with an Out of Hospital Ca...
Cardiovascular-Kidney-Metabolic Syndrome: Stage 4
Novel Therapy for Chronic Thromboembolic Pulmonary Disease: Balloon Pulmon...
Cardiovascular-Kidney-Metabolic Syndrome: Risk Enhancing Factors
Overview and Importance of the Cardiovascular-Kidney-Metabolic Syndrome...
Loading...
Save Video
Video is not available. Please check the URL.